• Explore /
  • Poster
  • / Retrospective cohort study to evaluate the efficacy and safety of T-DXd in HER2-positive unresectable advanced or recurrent gastric or gastroesophageal junction cancer: EN-DEAVOR study.

Retrospective cohort study to evaluate the efficacy and safety of T-DXd in HER2-positive unresectable advanced or recurrent gastric or gastroesophageal junction cancer: EN-DEAVOR study.

Abstract Poster

Authors

null

Koki Nakanishi

Nagoya University Graduate School of Medicine, Aichi, Japan

Koki Nakanishi , Yasuhiro Kodera , Hisato Kawakami , Akitaka Makiyama , Hirotaka Konishi , Satoshi Morita , Yukiya Narita , Naotoshi Sugimoto , Keiko Minashi , Motohiro Imano , Rin Inamoto , Hiroki Kume , Keita Yamaguchi , Wataru Hashimoto , Kei Muro

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach and Other Gastrointestinal Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Patient-Reported Outcomes and Real-World Evidence

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 274)

DOI

10.1200/JCO.2024.42.3_suppl.274

Abstract #

274

Poster Bd #

C12

Abstract Disclosures

Similar Posters

First Author: Daniel Olson

First Author: Shu Okamura

First Author: Toshiharu Hirose

First Author: Hiroaki Akamatsu